ENTA insider buying and SEC filings, explained
Enanta Pharmaceuticals Inc. · CIK 1177648
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$183K
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Dec 5, 2025 | Sale | Kathleen S. Capps (Officer) sold 323 shares at about $14.23 ($5K). Holdings down 4% to 8,377 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 5, 2025 |
| Dec 5, 2025 | Sale | Harry R. Trout III (CFO) sold 542 shares at about $14.23 ($8K). Holdings down 3% to 16,348 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 5, 2025 |
| Dec 5, 2025 | Sale | Scott T. Rottinghaus (Chief Medical Officer) sold 798 shares at about $14.23 ($11K). Holdings down 4% to 21,792 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 5, 2025 |
| Dec 5, 2025 | Sale | Brendan Luu (Chief Business Officer) sold 1,394 shares at about $14.23 ($20K). Holdings down 4% to 38,329 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 5, 2025 |
| Dec 5, 2025 | Sale | Tara Lynn Kieffer (Chief Product Strategy Officer) sold 2,106 shares at about $14.23 ($30K). Holdings down 6% to 30,620 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 5, 2025 |
| Dec 5, 2025 | Sale | Yat Sun Or (Chief Scientific Officer) sold 2,390 shares at about $14.23 ($34K). Holdings down 1% to 371,392 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 5, 2025 |
| Dec 5, 2025 | Sale | Jay R. Luly (CEO and Director) sold 4,743 shares at about $14.23 ($67K). Holdings down 1% to 858,026 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 5, 2025 |
| Dec 2, 2025 | Sale | Kathleen S. Capps (Officer) sold 207 shares at $13.96 ($3K). Holdings down 2% to 8,700 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 3, 2025 |
| Dec 2, 2025 | Sale | Harry R. Trout III (CFO) sold 380 shares at $13.96 ($5K). Holdings down 2% to 16,890 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 3, 2025 |
27 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow ENTA in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.